Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection - Wedemeyer, H; Schöneweis, K; Bogomolov, P O (Journal of Hepatology, 2019)
et al.